Metropolis Healthcare Limited announced the outcome of its Board Meeting held on May 13, 2026. The Board approved the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026. The financial results were issued with an unmodified opinion by the statutory auditors, B S R & Co. LLP. Additionally, the Board declared a second interim dividend of ₹1 per equity share (face value ₹2) for the financial year 2025-26. The record date for this dividend is May 19, 2026, and it will be paid within 30 days of declaration. The Board also recommended the appointment of M/s. Deloitte Haskins & Sells Chartered Accountants LLP as the new Statutory Auditors for a period of five years, replacing the retiring B S R & Co. LLP, subject to shareholder approval at the 26th Annual General Meeting (AGM). In senior management changes, Dr. Nilesh Shah will transition from his role as President - Internal Assurance to an advisory role, effective May 14, 2026. He will cease to be classified as Senior Management Personnel from the close of business hours on May 13, 2026. The board meeting commenced at 02:16 p.m. (IST) and concluded at 05:30 p.m. (IST).
